Location: Home
  • search
  • go
  • Relate News
  • 2/11/2026Betta Pharma Wins China Approval for Pertuzumab Biosimilar in Breast C...
  • 2/11/2026Eli Lilly's Omvoh Approved in China for Crohn's Disease and Ulcerative...
  • 2/11/2026China Issues Revised Rules for National Essential Drug List Management
  • 2/10/20263D Medicines Advances Envafolimab Toward Full Market Approval in China
  • 2/10/2026Cascade Raises $72M to Advance MASH, Obesity and Diabetes Pipeline
  • 2/10/2026Hengrui and Kailera Advance Obesity Therapy After Encouraging Mid-Stag...
  • 2/10/2026Insilico and CMS Partner on AI-Driven CNS and Autoimmune Drug Programs
  • 2/10/2026Weekly China Regulatory Roundup: EGFR, TROP2 Approvals and Broad IND A...
  • 2/10/2026AstraZeneca's China Business Hits New Heights as Record Revenue Boosts...
  • 2/10/2026China Biotech Lights Up. U.S. Stocks Prepare For A New Powerhouse (IBD...
  • 2/10/2026China Overhauls Drug Administration Rules, Emphasizing Quality and Cli...
  • 2/9/2026Lilly Expands China Partnership With Innovent in New Global Oncology a...
  • 2/9/2026GenSci Advances Autoimmune Pipeline as NMPA Clears First IND for GenSc...
  • 2/9/2026Ascletis Begins U.S. Phase II Trial of Oral GLP-1R Agonist ASC30 for T...
  • 2/9/2026Roche and Henlius–Organon Resolve U.S. Patent Dispute Over Pertuzumab...
  • 2/9/2026BioKangtai Cancels Planned Vaccine Joint Venture With AstraZeneca in C...
  • 2/9/2026InnoCare Wins China IND Clearance for VAV1 Molecular Glue Degrader ICP...
  • 2/9/2026J&J Wins China Approval Expanding Subcutaneous Daratumumab Use
  • 2/9/2026CDE Issues Technical Guideline for Generic Sodium Iodide [131I] Oral S...
  • 2/7/2026China Moves to Accelerate New Healthcare Insurance Models and Large‑S...
  • 2/7/2026Bio‑Thera and Avalon Forge 15‑Year Deal to Bring Keytruda Biosimilar...
  • 2/7/2026Delonix Secures IND Clearance for Novel MenB Vaccine DX-104 in China ...
  • 2/7/2026Recent Executive Moves
  • 2/6/2026China Launches Nationwide Crackdown on BMI Fraud in Mental Health Sect...
  • 2/6/2026Everest Medicines Gains Chinese Approval for VELSIPITY® in UC
  • 2/6/2026DCH Auriga Teams Up with Hengrui to Expand Innovative Medicines in HK ...
  • 2/6/2026Merck's Keytruda Wins New China Approval for Frontline Endometrial Can...
  • 2/6/2026Genturn Life Raises CNY Tens of Millions in Angel Round to Advance Re...
  • 2/6/2026Kelun-Biotech Expands Breast Cancer Indications of sac-TMT in China
  • 2/5/2026CDE Issues Technical Guideline for Clinical Trials of Chronic Insomnia...
  • Page:6/822 Total number of articles:24634: [First][<<] [4] [5] [6] [7] [8] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group